10-Q

Company

Viridian Therapeutics, Inc.\DE

Filed

August 8, 2023

Period of Report

June 30, 2023

Accession Number

0001590750-23-000008

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →